Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
暂无分享,去创建一个
[1] Tom Coenye,et al. Burkholderia cenocepacia sp. nov.--a new twist to an old story. , 2003, Research in microbiology.
[2] T. Coenye,et al. Comparative Assessment of Genotyping Methods for Epidemiologic Study of Burkholderia cepacia Genomovar III , 2002, Journal of Clinical Microbiology.
[3] P. Vandamme,et al. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. , 2002, FEMS immunology and medical microbiology.
[4] T. Coenye,et al. Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. , 2002, The Journal of infectious diseases.
[5] M. Corey,et al. Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada , 2002, Emerging infectious diseases.
[6] P. Gilligan,et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. , 2001, American journal of respiratory and critical care medicine.
[7] P. Corris,et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis , 2001, The Lancet.
[8] J. Lipuma,et al. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. , 2001, The Journal of pediatrics.
[9] P. Vandamme,et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Tom Coenye,et al. Taxonomy and Identification of the Burkholderia cepacia Complex , 2001, Journal of Clinical Microbiology.
[11] J. Lipuma. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? , 2001, Transplant infectious disease : an official journal of the Transplantation Society.
[12] M. Barchitta,et al. Burkholderia cepacia Complex Infection in Italian Patients with Cystic Fibrosis: Prevalence, Epidemiology, and Genomovar Status , 2001, Journal of Clinical Microbiology.
[13] J. Lipuma,et al. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. , 2001, American journal of respiratory and critical care medicine.
[14] J. Emerson,et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.
[15] P. Vandamme,et al. DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III , 2000, Journal of Clinical Microbiology.
[16] J. Burns,et al. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. , 2000, The Journal of infectious diseases.
[17] P. Whitby,et al. Species-Specific PCR as a Tool for the Identification of Burkholderia gladioli , 2000, Journal of Clinical Microbiology.
[18] P. Vandamme,et al. Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis Patients , 1999, Journal of Clinical Microbiology.
[19] J. Lipuma,et al. BURKHOLDERIA CEPACIA: Management Issues and New Insights , 1998 .
[20] J. Emerson,et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] C. Hart,et al. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia , 1998, Thorax.
[22] M. Kaufmann,et al. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. , 1996, Journal of medical microbiology.
[23] P. Gilligan,et al. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis , 1994, The Pediatric infectious disease journal.
[24] M. Dodd,et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis , 1993, The Lancet.
[25] T. Stull,et al. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis , 1993, Journal of clinical microbiology.
[26] J. Lipuma,et al. Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. , 1991, The Journal of infectious diseases.
[27] T. Edlind,et al. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. , 1988, The Journal of infectious diseases.
[28] M. Corey,et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. , 1984, The Journal of pediatrics.